| Title | Intervention |
NCT ID |
Sponsor | Status |
|---|---|---|---|---|
| Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer | Laboratory Biomarker Analysis, Nelipepimut-S Plus GM-CSF Vaccine, Sargramostim, Surgical Procedure | NCT02636582 | National Cancer Institute (NCI) | Active, not recruiting |
| Aging Mammary Stem Cells and Breast Cancer Prevention | Rapamycin | NCT02642094 | LuZhe Sun | Active, not recruiting |
| Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors | Carvedilol, Laboratory Biomarker Analysis, Pharmacogenomic Study, Pharmacological Study, Placebo Administration, Quality-of-Life Assessment, Questionnaire Administration | NCT02717507 | Children's Oncology Group | Active, not recruiting |
| Simvastatin in Reducing Pancreatitis in Patients With Recurrent, Acute or Chronic Pancreatitis | Laboratory Biomarker Analysis, Placebo Administration, Quality-of-Life Assessment, Questionnaire Administration, Simvastatin | NCT02743364 | National Cancer Institute (NCI) | Active, not recruiting |
| DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection | Electroporation-Mediated Plasmid DNA Vaccine Therapy, HCV DNA Vaccine INO-8000, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Rocakinogene Sifuplasmid | NCT02772003 | National Cancer Institute (NCI) | Active, not recruiting |
| The National Myelodysplastic Syndromes (MDS) Study | Therapeutic | NCT02775383 | National Heart, Lung, and Blood Institute (NHLBI) | Recruiting |
| Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive,... | Laboratory Biomarker Analysis, Sargramostim, pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine | NCT02780401 | University of Washington | Active, not recruiting |
| Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric... | Curcumin, Laboratory Biomarker Analysis, Placebo Administration, Quality-of-Life Assessment | NCT02782949 | National Cancer Institute (NCI) | Active, not recruiting |
| Understanding and Predicting Breast Cancer Events After Treatment | Cardiac MRI | NCT02791581 | Wake Forest University Health Sciences | Active, not recruiting |
| Chemoprevention of Gastric Carcinogenesis | Eflornithine, Eflornithine placebo | NCT02794428 | Vanderbilt-Ingram Cancer Center | Active, not recruiting |
Why I Joined a Clinical Trial
I participated in the STAR research study. I did so because I have always heard through research that I may be able to help someone else. Through this study, physician scientists will learn more ways of prevention and treatment. I have a strong family history of cancer, maybe this research will be helpful to the next generation.